The effect of dendritic cells activated by OK-432 and pulsed with antigens on cytokine induced killers

Biomedicine and Pharmacotherapy

Volumn 60, Issue 4, 2006, Pages 156-160

  Shu, Yong Qian ^a   Gu, Yanhong ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Cytokine induced killers; Dendritic cells; Lipopolysaccharide; OK 432

Indexed keywords

B7 ANTIGEN; CD83 ANTIGEN; HLA DR ANTIGEN; PICIBANIL; T6 ANTIGEN; CYTOKINE; LEUKOCYTE ANTIGEN;

ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL ACTIVATION; CELL FUNCTION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; DENDRITIC CELL; EVALUATION; HUMAN; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL; BIOSYNTHESIS; DRUG EFFECT; GENE EXPRESSION REGULATION; KILLER CELL; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE;

ANTIGENS, CD; CELL LINE, TUMOR; CELL PROLIFERATION; CYTOKINES; DENDRITIC CELLS; GENE EXPRESSION REGULATION; HUMANS; KILLER CELLS; PICIBANIL;

EID: 33744979017     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2006.03.001     Document Type: Article

References (12)

1. Bancher J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 66 (1998) 245-252
2. Schmidt-Wolf I.G.H., Lefterova P., Negrin R.S., et al. Sensitivity of multi drug resistant tumor cell lines to immunological effector cells. [J.]. Cellular Immunol. 169 1 (1996) 85-90
3. Schmidt-Wolf I.G.H., Negrin R.S., et al. Phenotypic characterization and identification of effecter cells involved in tumor cell recognition of cytokine induced killer cells. Exp. Hematol. 21 (1999) 1673-1679
4. Shu-yongqian Z.-y., and Dai-jun. The research of the maturation effector of human DCs from PBMC. [J]. The Journal of Chinese Biotherapy of Cancer 10 4 (2003) 243-247
5. Kaisho T., and Akira S. Toll-like receptors and their signaling mechanism in innate immunity. [J.]. Acta Odontol. Scand. 59 (2001) 124-130
6. Chen-xinqian, Jin-youyu, and Tang-guang. The new edited pharmacology[M]. The 5th edition (2003), The People's Health Publishing Company, Beijing (707)
7. Tsuyoshi I., Yuji U., Kaori O., et al. Streptococcalperparation OK-432 promotes functional maturation of human monocyte-drived dendritic cells. Cancer Immunol. Immunother. 52 (2003) 207-214
8. Toyokawa H., Inaba M., Takai S., et al. Enhancement of circulating dendritic cell cell activity by immunomodulators (OK-432 and KP-40). Anticancer Res. 22 (2002) 2137-2146
9. Marten A., Ziske C., Schottker B., et al. Interactions between dendritic cells and cytokine-induced killer cells lead to an activation of both populations. [J]. J. Immunother. 24 6 (2001) 502-510
10. Hongeng S., Petvises S., Worapongpaiboon S., et al. Generation of CD3+ CD56+ cytokine-induced killer cells and their in vitro cytotoxicity against pediatric cancer cells. [J]. Int. J. Hematol. 77 2 (2003) 175-179
11. Girolomoni G., and Ricciandi-Lastagnoli P. Dendritic cells hold promise for immunotherapy. Immunol. Today 18 (1997) 102
12. Shimizu K., Fields R.C., Giedlin M., et al. Systemic administration of interleukin 2 enhances therapeutic efficacy of dendritic cell-based tumor vaccines. Proc. Natl. Acad. Sci. USA 96 (1999) 2268